Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

11.01
Delayed Data
As of Sep 22
 +0.09 / +0.82%
Today’s Change
6.90
Today|||52-Week Range
11.63
+28.47%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Ross Steven A
Chief Information Officer
Sale6/05/201745,833$7.79$357.0K+41.52%
Van Oort Douglas M
Chairman & Chief Executive Officer
Sale2/02/201742,015$8.14$342.0K+36.77%
Van Oort Douglas M
Chairman & Chief Executive Officer
Buy2/02/2017200,000$1.71$342.0K+36.77%
Brodie Steven G
President-Pharmaceutical Services
Sale3/20/201733,450$7.90$264.3K+39.37%
Balliet Jennifer
Sale8/24/201722,500$9.38$211.1K+16.02%
Hannah Alison L
Director
Buy7/27/201720,000$9.19$183.8K+18.77%
Jones Steven C
Executive Vice President-Finance
Gift12/27/201620,000$8.92$178.4K+24.41%
Ross Steven A
Chief Information Officer
Buy6/02/201733,333$4.78$159.3K+41.34%
Ross Steven A
Chief Information Officer
Buy6/02/201737,500$3.93$147.4K+41.34%
Brodie Steven G
President-Pharmaceutical Services
Sale3/13/201716,550$8.00$132.4K+39.19%
Page of 3